Combination antihypertensive therapy with valsartan and hydrochlorothiazide in Chinese patients with mild-to-moderate hypertension

References

• Fujita T, Wu Z, Park JB,. et al. Briefings on JHS, CHS, KHS and THS guidelines and their difference from JNC VII and ESC/ESH. Int J Clin Pract 2006;60:3-6
   Web of Science ®Google Scholar
• Gu D, Reynolds K, Wu X, . InterASIA Collaborative Group . The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002; 40:920-7
   PubMed Web of Science ®Google Scholar
• Lawes CM, Rodgers A, Bennett DA,. et al. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003;21: 707-16
   PubMed Web of Science ®Google Scholar
• He J, Klag MJ, Wu Z,. et al. Stroke in the People's Republic of China. Stroke 1995;26:2222-7
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR,. et al. The Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. J Am Med Assoc 2003;289:2560-72
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A,. et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension [ESH-ESC Task Force on the Management of Arterial Hypertension]. J Hypertens 2007;25:1751-62
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Fujita T, Wu Z,. et al. Recommended optimal BP in the Asian population: difference from current JNC VII and ESC/ESH guidelines. Int J Clin Pract 2006;60:7-10
   Web of Science ®Google Scholar
• Chrysant SG. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study [Lisinopril-Hydrochlorothiazide group]. Arch Intern Med 1994; 154:737-43
   PubMed Web of Science ®Google Scholar
• Gradman AH, Acevedo C. Evolving strategies for the use of combination therapy in hypertension. Curr Hypertens Rep 2002;4:343-9
   PubMed Web of Science ®Google Scholar
• Wellington K, Faulds DM. Valsartan/hydrochlorothiazide: a review of its pharmacology, therapeutic efficacy and place in the management of hypertension. Drugs 2002;62:1983-2005
   PubMed Web of Science ®Google Scholar
• Neutel JM, Smith DH, Weber MA. Low-dose combination therapy: an important first-line treatment in the management of hypertension. Am J Hypertens 2001;14:286-92
   PubMed Web of Science ®Google Scholar
• Pool J, Oparil S, Hedner T,. et al. Dose-responsive antihypertensive efficacy of valsartan, a new angiotensin II-receptor blocker. Clin Ther 1998;20:1106-14
   PubMed Web of Science ®Google Scholar
• Parving HH, Lehnert H, Mortensen BJ,. et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. New Eng J Med 2001;345:870-8
   PubMed Web of Science ®Google Scholar
• Brenner BM, Cooper ME, Zeeuw DD,. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Eng J Med 2001;345:861-9
   PubMed Web of Science ®Google Scholar
• Maggioni AP, Anand I, Gottlieb SO,. et al. Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Amer Coll Cardiol 2002;40:1414-21
   PubMed Web of Science ®Google Scholar
• Hall WD. Efficacy and tolerability of valsartan in combination with hydrochlorothiazide in essential hypertension. Clin Drug Investig 1998;16:203-10
   PubMed Web of Science ®Google Scholar
• Mallion JM, Carretta R, Trenkwalder P,. et al. Valsartan/hydrochlorothiazide is effective in hypertensive patients inadequately controlled by valsartan monotherapy. Blood Press 2003;12: 36-43
   Web of Science ®Google Scholar
• Joint National Committee. The sixth report of the joint National Committee on prevention, detection, evaluation and treatment of blood pressure. Arch Intern Med 1997;157: 2413-46.
   Google Scholar
• Pool JL, Glazer R, Weinberger M,. et al. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Clin Ther 2007;29:61-73
   PubMed Web of Science ®Google Scholar
• Ofili EO. Dispelling the myth of ‘aggressive’ antihypertensive therapy. J Clin Hypertens (Greenwich) 2006;8:4-11
   PubMedGoogle Scholar
• Nash DT. Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide diuretics. Southern Med J 2007;100:386-92
   PubMed Web of Science ®Google Scholar
• Sica DA. Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs 2002;62:443-62
   PubMed Web of Science ®Google Scholar
• He J, Gu D, Wu X,. et al. Major causes of death among men and women in China. New Engl J Med 2005;353:1124-34
   PubMed Web of Science ®Google Scholar
• Huang J, Wildmanb RP, Gua D,. et al. Prevalence of isolated systolic and isolated diastolic hypertension subtypes in China. Am J Hypertens 2004;17:955-62
   PubMed Web of Science ®Google Scholar
• Aronow WS, Frishman WH. Treatment of hypertension and prevention of ischemic stroke. Curr Cardiol Rep 2004;6:124-9
   PubMedGoogle Scholar
• Zanchetti A, Waeber B. Hypertension: which aspects of hypertension should we impact on and how. J Hypertens 2006; 24:S2-S5
   Web of Science ®Google Scholar
• Ibrahim HR, Wenger NK. Secondary prevention of coronary heart disease in elderly patients. Am Fam Physician 2005; 71:2289-96
   PubMed Web of Science ®Google Scholar
• Hansson L, Zanchetti A, Carruthers SG,. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial [HOT Study Group]. Lancet 1998;351:1755-62
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc 1991;265: 3255-64
   PubMed Web of Science ®Google Scholar
• Wang GJ, Staessen JA, Franklin SS. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005;45:907-13
   PubMed Web of Science ®Google Scholar
• Lewington S, Clarke R, Qizilbash N,. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13
   PubMed Web of Science ®Google Scholar